Skip to main content
. 2021 Feb 19;35(4):e23735. doi: 10.1002/jcla.23735

FIGURE 3.

FIGURE 3

Analysis of structural proteins of SARS‐CoV‐2 with recombinant monoclonal antibodies. Western blotting of commercial MABs, in (A) reducing and (B) non‐reducing condition